| 000 | 00841 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250518062318.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a2072-6694 | ||
| 024 | 7 |
_a10.3390/cancers11101427 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGehringer, Franziska | |
| 245 | 0 | 0 |
_aFOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma. _h[electronic resource] |
| 260 |
_bCancers _cSep 2019 |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aWeissinger, Stephanie E | |
| 700 | 1 | _aSwier, Lotteke Jym | |
| 700 | 1 | _aMöller, Peter | |
| 700 | 1 | _aWirth, Thomas | |
| 700 | 1 | _aUshmorov, Alexey | |
| 773 | 0 |
_tCancers _gvol. 11 _gno. 10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3390/cancers11101427 _zAvailable from publisher's website |
| 999 |
_c30148133 _d30148133 |
||